AIkido Pharma, Inc.
(NASDAQ : SPEX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -0.92%725.152.6%$747.78m
AMGNAmgen, Inc. -0.36%230.121.4%$606.34m
BIIBBiogen, Inc. -1.11%259.351.8%$573.61m
MRNAModerna, Inc. -4.20%119.900.0%$565.19m
GILDGilead Sciences, Inc. -0.59%64.571.0%$546.83m
VRTXVertex Pharmaceuticals, Inc. -1.23%294.951.9%$424.62m
ILMNIllumina, Inc. -2.79%206.783.2%$399.37m
SNSSSunesis Pharmaceuticals, Inc. 1.99%4.100.7%$286.61m
SAVACassava Sciences, Inc. -5.74%39.920.0%$178.80m
BNTXBioNTech SE -1.69%135.210.0%$107.55m
TECHBio-Techne Corp. -4.46%295.314.5%$96.28m
BMRNBioMarin Pharmaceutical, Inc. -3.53%88.264.2%$92.55m
PRTAProthena Corp. Plc -3.14%56.7313.8%$76.72m
CRSPCRISPR Therapeutics AG -4.20%62.520.6%$74.93m
NVAXNovavax, Inc. -9.15%16.4375.6%$72.24m

Company Profile

AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.